| A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses K Yanaba, JD Bouaziz, KM Haas, JC Poe, M Fujimoto, TF Tedder Immunity 28 (5), 639-650, 2008 | 1485 | 2008 |
| Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression T Matsushita, K Yanaba, JD Bouaziz, M Fujimoto, TF Tedder The Journal of clinical investigation 118 (10), 3420-3430, 2008 | 1115 | 2008 |
| The development and function of regulatory B cells expressing IL-10 (B10 cells) requires antigen receptor diversity and TLR signals K Yanaba, JD Bouaziz, T Matsushita, T Tsubata, TF Tedder The Journal of Immunology 182 (12), 7459-7472, 2009 | 636 | 2009 |
| Regulatory B cells as inhibitors of immune responses and inflammation JD Bouaziz, K Yanaba, TF Tedder Immunological reviews 224 (1), 201-214, 2008 | 562 | 2008 |
| First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open … P Joly, M Maho-Vaillant, C Prost-Squarcioni, V Hebert, E Houivet, S Calbo, ... The Lancet 389 (10083), 2031-2040, 2017 | 502 | 2017 |
| B cell depletion reduces the development of atherosclerosis in mice H Ait-Oufella, O Herbin, JD Bouaziz, CJ Binder, C Uyttenhove, L Laurans, ... Journal of Experimental Medicine 207 (8), 1579-1587, 2010 | 491 | 2010 |
| B‐lymphocyte contributions to human autoimmune disease K Yanaba, JD Bouaziz, T Matsushita, CM Magro, EW St. Clair, TF Tedder Immunological reviews 223 (1), 284-299, 2008 | 430 | 2008 |
| Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice JD Bouaziz, K Yanaba, GM Venturi, Y Wang, RM Tisch, JC Poe, ... Proceedings of the National Academy of Sciences 104 (52), 20878-20883, 2007 | 386 | 2007 |
| Vascular skin symptoms in COVID-19: a French observational study JD Bouaziz, T Duong, M Jachiet, C Velter, P Lestang, C Cassius, ... J Eur Acad Dermatol Venereol 34 (9), e451-e452, 2020 | 366 | 2020 |
| IL‐10 produced by activated human B cells regulates CD4+ T‐cell activation in vitro JD Bouaziz, S Calbo, M Maho‐Vaillant, A Saussine, M Bagot, ... European journal of immunology 40 (10), 2686-2691, 2010 | 304 | 2010 |
| B lymphocyte depletion by CD20 monoclonal antibody prevents diabetes in nonobese diabetic mice despite isotype-specific differences in FcăR effector functions Y Xiu, CP Wong, JD Bouaziz, Y Hamaguchi, Y Wang, SM Pop, RM Tisch, ... The Journal of Immunology 180 (5), 2863-2875, 2008 | 273 | 2008 |
| B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis M Hasegawa, Y Hamaguchi, K Yanaba, JD Bouaziz, J Uchida, M Fujimoto, ... The American journal of pathology 169 (3), 954-966, 2006 | 247 | 2006 |
| Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus JI Silverberg, A Pinter, G Pulka, Y Poulin, JD Bouaziz, A Wollenberg, ... Journal of Allergy and Clinical Immunology 145 (1), 173-182, 2020 | 235 | 2020 |
| European Dermatology Forum S1‐guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes R Knobler, P Moinzadeh, N Hunzelmann, A Kreuter, A Cozzio, L Mouthon, ... Journal of the European Academy of Dermatology and Venereology 31 (9), 1401-1424, 2017 | 224 | 2017 |
| Chilblains is a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France A de Masson, JD Bouaziz, L Sulimovic, C Cassius, M Jachiet, MA Ionescu, ... Journal of the American academy of dermatology 83 (2), 667-670, 2020 | 222 | 2020 |
| Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients S Georgin‐Lavialle, B Terrier, AF Guedon, M Heiblig, T Comont, E Lazaro, ... British Journal of Dermatology 186 (3), 564-574, 2022 | 212 | 2022 |
| Dupilumab shows long-term safety and efficacy in patients with moderate to severe atopic dermatitis enrolled in a phase 3 open-label extension study M Deleuran, D Thaçi, LA Beck, M de Bruin-Weller, A Blauvelt, S Forman, ... Journal of the American Academy of Dermatology 82 (2), 377-388, 2020 | 211 | 2020 |
| Effectiveness and safety of dupilumab for the treatment of atopic dermatitis in a real-life French multicenter adult cohort S Faiz, J Giovannelli, C Podevin, M Jachiet, JD Bouaziz, Z Reguiai, ... Journal of the American Academy of Dermatology 81 (1), 143-151, 2019 | 184 | 2019 |
| CD24hiCD27+ and plasmablast-like regulatory B cells in human chronic graft-versus-host disease A de Masson, JD Bouaziz, H Le Buanec, M Robin, A O˘Meara, N Parquet, ... Blood, The Journal of the American Society of Hematology 125 (11), 1830-1839, 2015 | 182 | 2015 |
| Long‐term efficacy and safety of alemtuzumab in advanced primary cutaneous T‐cell lymphomas A De Masson, P Guitera, P Brice, I Moulonguet, F Mouly, JD Bouaziz, ... British Journal of Dermatology 170 (3), 720-724, 2014 | 119 | 2014 |
